Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation
Tetsuichi Yoshizato(Kyoto University), Seishi Ogawa(Kyoto University), Yoshinobu Kanda(Jichi Medical University), Yasunobu Nagata(Kyoto University), Keizo Horibe(Nagoya Medical Center), Claudia Haferlach(Munich Leukemia Laboratory (Germany)), Bartlomiej Przychodzen(Cleveland Clinic), Keisuke Kataoka(Maryland Oncology Hematology), Yuichi Shiraishi(The University of Tokyo), Kenichi Yoshida(Meiji University), Kosuke Aoki(Kyoto University), Masashi Sanada(Nagoya Medical Center), Torsten Haferlach(Munich Leukemia Laboratory (Germany)), Kenichi Chiba(The University of Tokyo), Yusuke Sato(Kyoto University), Yoshiko Atsuta(Aichi Medical University), Wolfgang Kern(Munich Leukemia Laboratory (Germany)), Nobuyuki Kakiuchi(Kyoto University), Yuka Iijima‐Yamashita(Nagoya Medical Center), Hideki Makishima(Kyoto University), Masahiro Nakagawa(Columbia University Irving Medical Center), Mikkael A. Sekeres(Cleveland Clinic), Yasuhito Nannya(Kyoto University), Keitaro Matsuo(Aichi Cancer Center), Yasushi Miyazaki(Nagasaki University), Makoto Onizuka(Tokai University), Jaroslaw P. Maciejewski(Cleveland Clinic), Satoru Miyano, Hiroko Tanaka(The University of Tokyo), Yusuke Shiozawa(Kyoto University), Hidehiro Itonaga(Nagasaki University), Hiromichi Suzuki(Kyoto University), Hiroo Ueno(Kansai Medical University)
Cited by 352
Related Papers
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k